Stem cell-based implants successfully secrete insulin in patients with type 1 糖尿病
日期:
December 2, 2021
来源:
Cell Press
概括:
Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 糖尿病. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic endoderm cells derived from human pluripotent stem cells (PSCs), were tested in 26 患者. While the insulin secreted by the implants did not have clinical effects in the patients, the data are the first reported evidence of meal-regulated insulin secretion by differentiated stem cells in human patients.
干细胞疗法
肝脏干细胞疗法
失代偿期肝硬化患者大多不得不选择肝移植, 但捐献器官的供应有限且成本高昂导致等待名单上的死亡率很高 . 自己身体的干细胞有帮助 阅读更多…